Elimination of imatinib mesylate and its metabolite N-desmethyl-imatinib

被引：15
|
作者：
Bornhäuser, M [1 ]
Pursche, S [1 ]
Bonin, M [1 ]
Freiberg-Richter, J [1 ]
Jenke, A [1 ]
Illmer, T [1 ]
Ehninger, G [1 ]
Schleyer, E [1 ]
机构：
[1] Univ Hosp, Dept Hematol Oncol, Dresden, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
10.1200/JCO.2005.05.246
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3855 / 3857
页数：3
相关论文
共 50 条
  • [1] Elimination of imatinib mesylate and its metabolite N-desmethyl-imatinib - In reply
    Peng, B
    Capdeville, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 3857 - 3858
  • [2] Should therapeutic drug monitoring of the unbound fraction of imatinib and its main active metabolite N-desmethyl-imatinib be developed?
    Gandia, Peggy
    Arellano, Cecile
    Lafont, Thierry
    Huguet, Francoise
    Malard, Laurence
    Chatelut, Etienne
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (02) : 531 - 536
  • [3] Should therapeutic drug monitoring of the unbound fraction of imatinib and its main active metabolite N-desmethyl-imatinib be developed?
    Peggy Gandia
    Cécile Arellano
    Thierry Lafont
    Françoise Huguet
    Laurence Malard
    Etienne Chatelut
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 531 - 536
  • [4] Pharmacokinetic profile of imatinib mesylate and N-desmethyl-imatinib (CGP 74588) in children with newly diagnosed Ph plus acute leukemias
    Marangon, Elena
    Citterio, Marco
    Sala, Federica
    Barisone, Elena
    Lippi, Alma Augusta
    Rizzari, Carmelo
    Biondi, Andrea
    D'Incalci, Maurizio
    Zucchetti, Massimo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (03) : 563 - 566
  • [5] Pharmacokinetic profile of imatinib mesylate and N-desmethyl-imatinib (CGP 74588) in children with newly diagnosed Ph+ acute leukemias
    Elena Marangon
    Marco Citterio
    Federica Sala
    Elena Barisone
    Alma Augusta Lippi
    Carmelo Rizzari
    Andrea Biondi
    Maurizio D’Incalci
    Massimo Zucchetti
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 563 - 566
  • [6] Pharmacokinetics and cellular uptake of imatinib and its main metabolite N-desmethyl-imatinib.
    Le Coutre, P
    Pursche, S
    Baskaynak, G
    von Bonin, M
    Kreuzer, KA
    Leopold, T
    Jenke, A
    Bornhäuser, M
    Ehninger, G
    Dörken, B
    Schleyer, E
    BLOOD, 2003, 102 (11) : 206B - 207B
  • [7] The Effect of Apigenin on Pharmacokinetics of Imatinib and Its Metabolite N-Desmethyl Imatinib in Rats
    Liu, Xian-yun
    Xu, Tao
    Li, Wan-shu
    Luo, Jun
    Geng, Pei-wu
    Wang, Li
    Xia, Meng-ming
    Chen, Meng-chun
    Yu, Lei
    Hu, Guo-xin
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [8] Role of imatinib metabolism in drug activity in a cohort of CML patients: Focus on N-desmethyl-imatinib
    Philibert, L.
    Tondeur, S.
    Quittet, P.
    Bressolle, F.
    Mathieu, O.
    Pinguet, F.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 : 43 - 43
  • [9] The effect of grape seed and green tea extracts on the pharmacokinetics of imatinib and its main metabolite, N-desmethyl imatinib, in rats
    Darweesh, Ruba S.
    El-Elimat, Tamam
    Zayed, Aref
    Khamis, Tareq N.
    Babaresh, Wahby M.
    Arafat, Tawfiq
    Al Sharie, Ahmed H.
    BMC PHARMACOLOGY & TOXICOLOGY, 2020, 21 (01):
  • [10] The effect of grape seed and green tea extracts on the pharmacokinetics of imatinib and its main metabolite, N-desmethyl imatinib, in rats
    Ruba S. Darweesh
    Tamam El-Elimat
    Aref Zayed
    Tareq N. Khamis
    Wahby M. Babaresh
    Tawfiq Arafat
    Ahmed H. Al Sharie
    BMC Pharmacology and Toxicology, 21
12345